NFlection Therapeutics, Inc.
Topical MEK inhibitor gel (NFX) for cutaneous squamous cell carcinoma chemoprevention in organ transplant recipients
- Sector
- Medtech
- Headquarters
- WAYNE, PA
- Founded
- 2014
- Latest Form D
- $4M, Jul 2023
- Total capital
- $15.7M
- Federal grants
- $300K
- 1 award
- Rank in peer group#5 of 23
- Private capital raised
- $15.4M
- 3 Form D · last Jul 2023
- 39 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 17 pending · first 2021
- Rank in peer group#3 of 23
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$4M
- Private capital raisedForm D · SEC · 2nd filing$10M
- Private capital raisedForm D · SEC · 1st filing$1.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 23 peers
Line = medianMedtech · Molecule
- Federal grants#5 · top 22%
- Granted patents#3 · top 13%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Christopher PowalaResearcherExecutive Officer, DirectorLinked by 1 patent · $300K in grants as PI
- Corey GoodmanDirectorNamed in SEC Form D filings
- Josh GrassDirectorNamed in SEC Form D filings
- Ketan PatelDirectorNamed in SEC Form D filings
- Mark de SouzaExecutive Officer, DirectorNamed in SEC Form D filings
- Michael WoottonExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
- William HodderExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 24- PendingThienyl-aniline Compounds For Treatment Of Dermal DisordersUSPTOApplication 19356850
- GrantedCrystalline Forms Of A Pyrrolopyridine-aniline CompoundUSPTOUS 12,649,742
- PendingPyrrolopyridine-aniline Compounds For Treatment Of Dermal DisordersUSPTOApplication 19312825
Show all 24 patent records
- Thienyl-aniline Compounds For Treatment Of Dermal DisordersJun 18, 2026 · Application 19356850Pending
- Crystalline Forms Of A Pyrrolopyridine-aniline CompoundJun 9, 2026 · US 12,649,742Granted
- Pyrrolopyridine-aniline Compounds For Treatment Of Dermal DisordersDec 25, 2025 · Application 19312825Pending
- Thienyl-aniline Compounds For Treatment Of Dermal DisordersNov 11, 2025 · US 12,466,818Granted
- Formulations Of Pyrrolopyridine-aniline CompoundsOct 2, 2025 · Application 19187102Pending
- Naphthyridinone-aniline Compounds For Treatment Of Dermal DisordersAug 5, 2025 · US 12,378,240Granted
- Formulations Of Pyrrolopyridine-aniline CompoundsMay 27, 2025 · US 12,310,950Granted
- Processes For Preparing Pyrrolopyridine-aniline CompoundsJul 11, 2024 · Application 18273322Pending
- Cyanoaryl-aniline Compounds For Treatment Of Dermal DisordersFeb 7, 2023 · US 11,572,344Granted
- Fused Heteroaromatic-aniline Compounds For Treatment Of Dermal DisordersJan 3, 2023 · US 11,542,271Granted
- Treatment Of Cognitive Dysfunction With Pyrrolopyridine-aniline CompoundsApr 14, 2022 · Application 17483468Pending
- Fused Heteroaromatic-aniline Compounds For Treatment Of Dermal DisordersApr 27, 2021 · US 10,988,483Granted
- Treatment Of Cognitive Dysfunction With Pyrrolopyridine-aniline CompoundsApplication PCTUS2021051710Pending
- Formulations Of Pyrrolopyridine-aniline CompoundsApplication 63282395Pending
- Crystalline Forms Of A Pyrrolopyridine-aniline CompoundApplication PCTUS2022013146Pending
- Processes For Preparing Pyrrolopyridine-aniline CompoundsApplication PCTUS2022013153Pending
- Crystalline Forms Of A Pyrrolopyridine-aniline CompoundApplication 63139975Pending
- Processes For Preparing Pyrrolopyridine-aniline CompoundsApplication 63139981Pending
- Treatment Of Cognitive Dysfunction With Pyrrolopyridine-aniline CompoundsApplication 63082595Pending
- Thienyl-aniline Compounds For Treatment Of Dermal DisordersApplication PCTUS2019000067Pending
- Cyanoaryl-aniline Compounds For Treatment Of Dermal DisordersApplication PCTUS2019000068Pending
- Naphthyridinone-aniline Compounds For Treatment Of Dermal DisordersApplication PCTUS2019000070Pending
- Topical FormulationsApplication PCTUS2019000066Pending
- Formulations Of Pyrrolopyridine-aniline CompoundsApplication PCTUS2022050794Pending
Related companies, and why
- CICONIA MEDICAL INCSimilar federal contract value in Medtech · null in contracts
- AMAHEALTH LLCSimilar federal contract value in Medtech · null in contracts
- MARIZYME, INC.Similar federal contract value in Medtech · null in contracts
- CALYX, INC.Similar federal contract value in Medtech · null in contracts
- PROGENTEC DIAGNOSTICS, INC.Similar federal contract value in Medtech · null in contracts
- Inogen IncSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .